View Cart  

French Agency Says Its HTA Scheme Will Improve Device Comparisons

France’s National Health Authority (HAS) will conduct a cost-utility analysis followed by a cost-effectiveness analysis to evaluate medical devices that are expected to impact health-related quality of life, according to a new guide on economic evaluation of health interventions.

To View This Article:


Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00